Insulin therapy for adult patients with type 2 diabetes mellitus

A position statement of the korean diabetes association, 2017

byungwan lee, Jin Hwa Kim, Seung Hyun Ko, Kyu Yeon Hur, Nan Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok O. Park, Kyung Mook Choi

Research output: Contribution to journalReview article

Abstract

The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

Original languageEnglish
Pages (from-to)967-973
Number of pages7
JournalKorean Journal of Internal Medicine
Volume32
Issue number6
DOIs
Publication statusPublished - 2017 Nov 1

Fingerprint

Type 2 Diabetes Mellitus
Insulin
Clinical Trials
Therapeutics
Practice Guidelines
Hypoglycemic Agents
Physicians
Safety

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

lee, byungwan ; Kim, Jin Hwa ; Ko, Seung Hyun ; Hur, Kyu Yeon ; Kim, Nan Hee ; Rhee, Sang Youl ; Kim, Hyun Jin ; Moon, Min Kyong ; Park, Seok O. ; Choi, Kyung Mook. / Insulin therapy for adult patients with type 2 diabetes mellitus : A position statement of the korean diabetes association, 2017. In: Korean Journal of Internal Medicine. 2017 ; Vol. 32, No. 6. pp. 967-973.
@article{795fa1df75454c48a3696e5cabf5e767,
title = "Insulin therapy for adult patients with type 2 diabetes mellitus: A position statement of the korean diabetes association, 2017",
abstract = "The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.",
author = "byungwan lee and Kim, {Jin Hwa} and Ko, {Seung Hyun} and Hur, {Kyu Yeon} and Kim, {Nan Hee} and Rhee, {Sang Youl} and Kim, {Hyun Jin} and Moon, {Min Kyong} and Park, {Seok O.} and Choi, {Kyung Mook}",
year = "2017",
month = "11",
day = "1",
doi = "10.3904/kjim.2017.314",
language = "English",
volume = "32",
pages = "967--973",
journal = "Korean Journal of Internal Medicine",
issn = "1226-3303",
publisher = "Korean Association of Internal Medicine",
number = "6",

}

Insulin therapy for adult patients with type 2 diabetes mellitus : A position statement of the korean diabetes association, 2017. / lee, byungwan; Kim, Jin Hwa; Ko, Seung Hyun; Hur, Kyu Yeon; Kim, Nan Hee; Rhee, Sang Youl; Kim, Hyun Jin; Moon, Min Kyong; Park, Seok O.; Choi, Kyung Mook.

In: Korean Journal of Internal Medicine, Vol. 32, No. 6, 01.11.2017, p. 967-973.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Insulin therapy for adult patients with type 2 diabetes mellitus

T2 - A position statement of the korean diabetes association, 2017

AU - lee, byungwan

AU - Kim, Jin Hwa

AU - Ko, Seung Hyun

AU - Hur, Kyu Yeon

AU - Kim, Nan Hee

AU - Rhee, Sang Youl

AU - Kim, Hyun Jin

AU - Moon, Min Kyong

AU - Park, Seok O.

AU - Choi, Kyung Mook

PY - 2017/11/1

Y1 - 2017/11/1

N2 - The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

AB - The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

UR - http://www.scopus.com/inward/record.url?scp=85034618483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034618483&partnerID=8YFLogxK

U2 - 10.3904/kjim.2017.314

DO - 10.3904/kjim.2017.314

M3 - Review article

VL - 32

SP - 967

EP - 973

JO - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

SN - 1226-3303

IS - 6

ER -